Artiva Biotherapeutics, Inc. Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (2)
- Services Agreements (6)
- Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation) (Filed With SEC on June 28, 2024)
- Form of Indemnification Agreement by and between the Registrant and its directors and officers (Filed With SEC on June 28, 2024)
- Amendment No. 1 to Strategic Collaboration Agreement, dated October 18, 2021, by and between the Registrant and Affimed GmbH (Filed With SEC on December 16, 2021)
- Strategic Collaboration Agreement, dated November 5, 2020, by and between the Company and Affimed GmbH (Filed With SEC on April 8, 2021)
- Exclusive License and Collaboration Agreement, dated January 27, 2021, by and between the Registrant and Merck Sharp & Dohme Corp (Filed With SEC on April 8, 2021)
- Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and Green Cross Cell Corporation (Filed With SEC on April 8, 2021)
- Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and Green Cross Cell Corporation (Filed With SEC on April 8, 2021)
- Form of Indemnification Agreement by and between the Registrant and its directors and officers (Filed With SEC on April 8, 2021)
